The Drug Strategy Community Initiatives Fund -- At a Glance
In response to the rising level of problematic substance use in
Canada, the federal government renewed its commitment to Canada's
Drug Strategy in 2003. As part of its five-year action plan,
Health Canada launched the Drug Strategy Community Initiatives
Fund (DSCIF) in April 2004.
The Drug Strategy Community Initiatives Fund aims to tackle problematic
substance use on two key fronts: (1) Promotion and Prevention and
(2) Harm Reduction. Within these two funding areas,
eligible applicants can include: not-for-profit health organizations,
educational institutions, business associations, charitable groups,
and off-reserve Aboriginal groups, among others. Proposals may
embrace a wide range of projects and activities, and must conform
to eligibility requirements.
Examples of projects that would fall under the theme of Promotion
and Prevention are: public information campaigns, life skills training,
promoting healthy lifestyles and productive behaviours, and discouraging
problematic substance use in the first place, among others.
The Harm Reduction component may include such activities as: outreach,
pilot projects, setting up peer support networks and awareness
programs on injection drug use.
Proposals reflecting a "countrywide" mandate or scope
of activity will be processed through the national funding component
at Health Canada's Ottawa headquarters. Applications covering
projects with a provincial/territorial or local scope will be processed
through the regional funding component. Health Canada offices are
located in Halifax, Montréal, Ottawa, Toronto, Winnipeg,
Edmonton and Vancouver.
How You Can Get More Information
For more information about the Drug Strategy Community Initiatives
Fund (including the application process), and how you can play
a part in its success story, please refer to Drug
Strategy Community Initiatives Fund - Funding Guidelines. If you wish to
receive details by post, please write to the following address:
Community Initiatives Division, Drug Strategy and Controlled Substances
Programme, Health Canada, 123 Slater Street, Ottawa, Ontario, K1A
0K9.
|